Immunohistochemical study of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human endometrial carcinoma

Anticancer Research

Volumn 18, Issue 3 A, 1998, Pages 1661-1664

  Ito, Kiyoshi ^a   Sasano, Hironobu ^a,b   Yoshida, Yuuji ^a   Sato, Shinji ^a   Yajima, Akira ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Cancer immunohistochemistry; Cyclin dependent kinase; Cyclins; Endometrium

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN E;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; ENDOMETRIUM CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADULT; AGED; CDC2-CDC28 KINASES; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; CYCLINS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MITOTIC INDEX; NEOPLASM STAGING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS;

EID: 0031858809     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Cordon-Cardo C: Mutation of cell cycle regulators- biological and clinical implications for human neoplasia. Am J Pathol 147: 545-560, 1995.
2. Nurse P: Universal control mechanism in regulating onset of M-phase. Nature 344: 503-508, 1990.
3. Reed SI: The role of p34 kinases in the G1 to S-phase transition. Annu Rev Cell Biol 8: 529-561, 1992.
4. Akiyama N, Tsuruta H, Sasaki H, Sakamoto H, Hamaguchi M, Ohmura Y: Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11 ;14)(q13;q32). Cancer Res 54: 377-379, 1994.
5. Zhang YG, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM: Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 196: 1010-1016, 1993.
6. Leach SF, Elledge SJ, Sherr CJ, Willpson JKV, Markowitz S, Kinzler KW: Amplification of cyclin genes in colorectal carcinomas. Cancer Res 53: 1986-1989, 1993.
7. Jiang W, Kahn SM, Tomita N, Zhang YJ, Lu SH, Weinstein B: Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 52: 2980-2983, 1993.
8. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J: Cyclin D1 protein expression and function in human breast cancer 57: 353-361, 1994.
9. Keyomarsi K, O'leary N, Molnar G, Lees E, Fingert HJ, Pardee AB: Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54: 380-385, 1994.
10. Sasano H, Frost AR, Saitou R, Taniyama Y, Nagura H, Matsunaga G, Takehana K, Kimura M, Silverberg SG: Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma. Anticancer Res 17: 3685-3690, 1997.
11. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP: Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS and MDM2. Cancer Res 54: 4299-4303, 1994.
12. He J, Allen JR, Collins P, Allalunis-Turner MJ, Godbout R, Day RS 111, James CD: CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res 54: 5804-5807, 1994.
13. Nikaido T, Li SF, Shiozaki T, Fujii S: Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas. Cancer 78: 1248-1253, 1996.
14. Li SF, Shiozaki T, Nakayama K, Nikaido T, Fujii S: Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma. Cancer 77: 321-328, 1996.
15. FIGO News. Int J Gynecol Obstet 28: 139, 1989.
16. Sasano H, Nagura H, Harada N, Goukon Y, Kimura M: Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol 25: 530-535, 1994.
17. Sasano H, Miyazaki S, Goukon Y, Nishihira T, Sawai T, Nagura H: Expression of p53 in human esophageal carcinoma: An immunohistochemical study with correlation to proliferating cell nuclear antigen expression. Hum Pathol 23: 1238-1243, 1992.
18. Ito K, Sasano H, Matsunaga G, Sato S, Yajima A, Nasim S, Garrett CT: Correlations between p21 expression and clinicopathological findings, p53 gene and protein alterations, and survival in patients with endometrial carcinoma. J Pathol 183: 3: 318-324, 1997.
19. Dong Y et al: increased expression of cyclin dependent kinase inhibitor 2 (CDKN2A) gene product p161 NK4A in ovarian cancer was associated with progression and unfavourable prognosis. Int J Cancer 74: 57-63, 1997.